• Alpha 1 Antitrypsin, Serum
  • Amyotrophic Lateral Sclerosis Gene Mutation Panel, NGS
  • Eosinophil Cationic Protein
  • Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
  • Hereditary Angioedema Diagnostic Panel
  • Allergy Screen
  • Lipoprotein Profile (Lipoprotein Particle), High Resolution Fractionation and Quantitation
  • Actinomyces, Molecular Method
  • Fungal Culture, Body Fluid
  • Alpha-L-Iduronidase (IDUA) Gene Mutation Analysis, Full Sequencing
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
Medical Test

Interpretation
Access to CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis is restricted.
Loading...